Co-Diagnostics, Inc., a molecular diagnostics company, will host a booth at WHX Kuala Lumpur from July 16-18, 2025, at the Malaysia International Trade and Exhibition Centre. The company plans to increase interest in its suite of PCR in vitro diagnostics for infectious diseases, promote its Co-Primers® technology, and introduce its upcoming Co-Dx™ PCR platform, including the Co-Dx PCR MTB test and the 8-plex Co-Dx HPV test.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.